Published in Am J Gastroenterol on June 01, 2000
Percutaneous endoscopic gastrostomy: indications, technique, complications and management. World J Gastroenterol (2014) 1.47
Complications of and controversies associated with percutaneous endoscopic gastrostomy: report of a case and literature review. Medscape J Med (2008) 1.38
Natural history of feeding-tube use in nursing home residents with advanced dementia. J Am Med Dir Assoc (2009) 1.34
Percutaneous endoscopic gastrostomy (PEG): retrospective analysis of a 7-year clinical experience. Acta Inform Med (2012) 1.23
Does feeding tube insertion and its timing improve survival? J Am Geriatr Soc (2012) 1.22
Complication rate lower after percutaneous endoscopic gastrostomy than after surgical gastrostomy: a prospective, randomized trial. Surg Endosc (2006) 1.20
Senescent swallowing: impact, strategies, and interventions. Nutr Clin Pract (2009) 1.12
Indications for percutaneous endoscopic gastrostomy and survival in old adults. Food Nutr Res (2011) 1.08
Trends in the use of feeding tubes in North Carolina hospitals. J Gen Intern Med (2004) 1.06
[PEG tube placement in German geriatric wards - a retrospective data-base analysis]. Z Gerontol Geriatr (2007) 0.84
The role of gastrostomy tube placement in advanced dementia with dysphagia: a critical review. Clin Interv Aging (2014) 0.83
Predictive factors for early mortality after percutaneous endoscopic and radiologically-inserted gastrostomy. Dig Dis Sci (2013) 0.80
Factors predicting early discharge and mortality in post-percutaneous endoscopic gastrostomy patients. Ann Gastroenterol (2014) 0.79
Proton pump inhibitor use before percutaneous endoscopic gastrostomy is associated with adverse outcomes. Gut Liver (2014) 0.77
Investigation of the Existence of Supplier-Induced Demand in use of Gastrostomy Among Older Adults: A Retrospective Cohort Study. Medicine (Baltimore) (2016) 0.77
Artificial nutrition and hydration: the evolution of ethics, evidence, and policy. J Gen Intern Med (2011) 0.77
Basic geriatric assessment does not predict in-hospital mortality after PEG placement. BMC Geriatr (2012) 0.76
Re: Saunders et al.--High mortality rate after percutaneous endoscopic gastrostomy in patients with dementia. Am J Gastroenterol (2001) 0.75
Percutaneous endoscopic gastrostomy in patients with dementia. Am J Gastroenterol (2001) 0.75
Special considerations for endoscopists on PEG indications in older patients. ISRN Gastroenterol (2012) 0.75
Thirty-day mortality after percutaneous gastrostomy by endoscopic versus radiologic placement: a systematic review and meta-analysis. Intest Res (2016) 0.75
Percutaneous Endoscopic Gastrostomy: Mortality and Risk Factors for Survival. Gastroenterology Res (2012) 0.75
End-of-life care issues in advanced dementia. Ment Health Fam Med (2013) 0.75
Artificially giving nutrition and fluids is not one action. BMJ (2003) 0.75
Is short-term percutaneous endoscopic gastrostomy tube placement beneficial in acutely ill cognitively intact elderly patients? A proposed decision-making algorithm. Geriatr Gerontol Int (2014) 0.75
The Effects of Percutaneous Endoscopic Gastrostomy on Quality of Life in Patients With Dementia. Gastroenterology Res (2012) 0.75
Long-Term Survival of Patients Receiving Artificial Nutrition in Japanese Psychiatric Hospitals. Dement Geriatr Cogn Dis Extra (2016) 0.75
Feeding tubes in dementia: is there an effective UK strategy? BMJ (2004) 0.75
Outcomes and Safety Issues Related to Percutaneous Endoscopic Gastrostomy in Neurodegenerative Diseases. Clin Endosc (2017) 0.75
Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care. Lancet (2001) 5.56
Poverty and public health--new outlooks. I. Poverty as an obstacle to health progress in our cities. Am J Public Health Nations Health (1965) 4.53
Biofilms, the customized microniche. J Bacteriol (1994) 4.33
Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study. Helicobacter (1996) 3.13
Ranitidine and cimetidine in prevention of duodenal ulcer relapse. A double-blind, randomised, multicentre, comparative trial. Lancet (1984) 3.11
Mortality in Barrett's esophagus: three decades of experience at a single center. Endoscopy (2012) 2.67
The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. Gastroenterology (1999) 2.64
The anti-coronary club. A dietary approach to the prevention of coronary heart disease--a seven-year report. Am J Public Health Nations Health (1966) 2.42
FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains. Cell (1992) 2.28
Clostridium difficile associated diarrhoea: a role in inflammatory bowel disease? Lancet (1980) 2.26
Preoperative assessment as a predictor of mortality and morbidity after lung resection. Am Rev Respir Dis (1989) 2.26
Refractory duodenal ulcer. Gut (1984) 2.25
The nucleotide sequence of sacbrood virus of the honey bee: an insect picorna-like virus. J Gen Virol (1999) 2.16
Management considerations for an HIV positive dental student. J Dent Educ (1991) 2.14
Sacbrood virus of the honeybee (Apis mellifera): rapid identification and phylogenetic analysis using reverse transcription-PCR. Clin Diagn Lab Immunol (2001) 2.08
Hospital epidemiology. Its development and potential. JAMA (1965) 2.05
Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Aliment Pharmacol Ther (2001) 2.04
One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group. Gut (1997) 2.00
Species identification and subtyping of Ureaplasma parvum and Ureaplasma urealyticum using PCR-based assays. J Clin Microbiol (2000) 1.94
Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia. Gut (1997) 1.88
Emergency admissions for upper gastrointestinal disease and their relation to NSAID use. Aliment Pharmacol Ther (1997) 1.86
Helicobacter pylori antimicrobial resistance in the United Kingdom: the effect of age, sex and socio-economic status. Aliment Pharmacol Ther (2001) 1.81
Carbonic anhydrase activity of mucosa of small intestine and colon. Nature (1968) 1.81
Micro semi-automated analysis of surface and wastewaters for chemical oxygen demand. Anal Chem (1975) 1.73
Does treatment with cimetidine extended beyond initial healing of duodenal ulcer reduce the subsequent relapse rate? Br Med J (Clin Res Ed) (1982) 1.69
Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile. Gut (1986) 1.61
Design and development of pilus vaccines for Haemophilus influenzae diseases. Pediatr Infect Dis J (1989) 1.60
Prevalence of Clostridium difficile on a mixed-function ward for the elderly. J Infect (1990) 1.59
The complete sequence of a human astrovirus. J Gen Virol (1994) 1.57
Oral metronidazole in Clostridium difficile colitis. Br Med J (1979) 1.56
Carbonic anhydrase: isoenzymes, properties, distribution, and functional significance. Biol Rev Camb Philos Soc (1972) 1.53
Growth and characterisation of human faecal astrovirus in a continuous cell line. Arch Virol (1990) 1.53
Bile acid malabsorption in persistent diarrhoea. J R Coll Physicians Lond (2001) 1.49
Phylogenetic analysis of Ureaplasma urealyticum--support for the establishment of a new species, Ureaplasma parvum. Int J Syst Bacteriol (1999) 1.49
A comparison of two different doses of omeprazole versus ranitidine in treatment of duodenal ulcers. J Clin Gastroenterol (1986) 1.46
Report of the Working Party of the Endoscopy Committee of the British Society of Gastroenterology on the reuse of endoscopic accessories. Gut (1998) 1.44
Double-blind comparison of cimetidine and placebo in the maintenance of healing of chronic duodenal ulceration. Gut (1979) 1.43
The human astrovirus RNA-dependent RNA polymerase coding region is expressed by ribosomal frameshifting. J Virol (1994) 1.41
Cimetidine in "chickenpox oesophagitis". Br Med J (1978) 1.39
Vancomycin dose for pseudomembranous colitis. Lancet (1980) 1.39
Biofilm maturity studies indicate sharp debridement opens a time- dependent therapeutic window. J Wound Care (2010) 1.39
Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections. J Antimicrob Chemother (2008) 1.37
Plasmid-mediated resistance to gentamicin in Staphylococcus aureus. Antimicrob Agents Chemother (1977) 1.36
Asymptomatic neonatal colonisation by Clostridium difficile. Arch Dis Child (1984) 1.34
The role of dietary fiber in satiety, glucose, and insulin: studies with fruit and fruit juice. Am J Clin Nutr (1981) 1.32
Identification and sequence determination of the capsid protein gene of human astrovirus serotype 1. FEMS Microbiol Lett (1993) 1.32
The future role of schools of public health. I. Am J Public Health Nations Health (1970) 1.27
Species-specific PCR for identification of common contaminant mollicutes in cell culture. Appl Environ Microbiol (2001) 1.27
Family planning and the Department of Health of the city of New York. Bull N Y Acad Med (1966) 1.26
Upper gastrointestinal endoscopy: its effects on patient management. Br Med J (1979) 1.26
Defective translation of measles virus matrix protein in a subacute sclerosing panencephalitis cell line. Nature (1983) 1.25
Measles virus gene expression in subacute sclerosing panencephalitis. Virus Res (1984) 1.22
Role of an improvement in acid-base status and nutrition in CAPD patients. Kidney Int (1997) 1.22
Intermittent treatment of duodenal ulcer with cimetidine. Br Med J (1980) 1.20
Acute arthritis associated with Clostridium difficile colitis. Br Med J (Clin Res Ed) (1981) 1.18
Regulation of glomerular filtration rate in chronic congestive heart failure patients. Kidney Int (1988) 1.18
Functions of optic nerve glia: axoglial signalling in physiology and pathology. Eye (Lond) (2004) 1.17
Characterization of the microflora of the human axilla. Int J Cosmet Sci (2003) 1.17
Percutaneous endoscopic gastrostomy: a prospective analysis of hospital support required and complications following discharge to the community. Eur J Clin Nutr (2001) 1.17
Cell culture adaptation of astrovirus involves a deletion. J Virol (1994) 1.17
Aminoglycoside modification by gentamicin-resistant isolates of Staphylococcus aureus. Antimicrob Agents Chemother (1978) 1.17
Measles virus persistency and disease. Prog Med Virol (1984) 1.16
Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention. Aliment Pharmacol Ther (2013) 1.15
Systematic review: do we need a new gastro-oesophageal reflux disease questionnaire? Aliment Pharmacol Ther (2004) 1.15
Differential protein expression in the prefrontal white matter of human alcoholics: a proteomics study. Mol Psychiatry (2006) 1.13
The 3' terminal sequence of a human astrovirus. Arch Virol (1992) 1.12
Changing phage typing patterns of epidemic gentamicin-resistant Staphylococcus aureus. Evidence for transmission of gentamicin resistance. Lancet (1979) 1.12
Recent trends in hospital admissions and mortality rates for peptic ulcer in Scotland 1982-2002. Aliment Pharmacol Ther (2006) 1.12
Severe hypothermia as a result of barbiturate overdose complicated by cardiac arrest. Lancet (1968) 1.11
The 5' untranslated region of Rhopalosiphum padi virus contains an internal ribosome entry site which functions efficiently in mammalian, plant, and insect translation systems. J Virol (2001) 1.10
Adaptation of coronavirus JHM to persistent infection of murine sac(-) cells. J Gen Virol (1984) 1.10
Relationships between monoclonal antibody-binding sites on the measles virus haemagglutinin. J Gen Virol (1982) 1.09
Quantitative RT-PCR for the enumeration of noroviruses (Norwalk-like viruses) in water and sewage. Lett Appl Microbiol (2004) 1.09
A dot-blot hybridization procedure for the detection of astrovirus in stool samples. Epidemiol Infect (1991) 1.08
Heterotypic serologic responses after yellow fever vaccination; detection of persons with past St. Louis encephalitis or dengue. J Immunol (1967) 1.08
The role and contribution of epidemiology in planning, operation, and evaluation of Regional Medical Programs (heart, cancer, and stroke). I. Epidemiology and Regional Medical Programs. Am J Public Health Nations Health (1968) 1.08
Identification by 16S rRNA gene analyses of a potential novel mycobacterial species as an etiological agent of canine leproid granuloma syndrome. J Clin Microbiol (2000) 1.08
Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users. Aliment Pharmacol Ther (1998) 1.07
Prospective validation of the Rockall risk scoring system for upper GI hemorrhage in subgroups of patients with varices and peptic ulcers. Am J Gastroenterol (2002) 1.06
Insights into 'fermentonomics': evaluation of volatile organic compounds (VOCs) in human disease using an electronic 'e-nose'. J Med Eng Technol (2011) 1.05
Six years of continuous cimetidine treatment in peptic ulcer disease: efficacy and safety. Anglo-Irish Cimetidine Long-Term Study Group. Aliment Pharmacol Ther (1988) 1.04
Application of electronmicroscopy, enzyme immunoassay, and RT-PCR to monitor an outbreak of astrovirus type 1 in a paediatric bone marrow transplant unit. J Med Virol (1999) 1.04
Percutaneous endoscopic gastrostomy: an effective strategy for gastrostomy feeding in patients with dementia. Clin Med (2004) 1.03
Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study Group. Ital J Gastroenterol Hepatol (1998) 1.03
Prevalence and correlates of vertebral fractures in adults with cystic fibrosis. Bone (2004) 1.02
The isoenzymes of carbonic anhydrase: tissue, subcellular distribution and functional significance, with particular reference to the intestinal tract. J Physiol (1971) 1.02
Sources and impact of artifacts on clinical three-dimensional ultrasound imaging. Ultrasound Obstet Gynecol (2000) 1.02
Seroprevalence of astrovirus types 1 and 6 in London, determined using recombinant virus antigen. Epidemiol Infect (1996) 1.01
Evaluation of gut bacterial populations using an electronic e-nose and field asymmetric ion mobility spectrometry: further insights into 'fermentonomics'. J Med Eng Technol (2012) 1.01
Intravenous sedation for upper gastrointestinal endoscopy: diazepam versus midazolam. Br Med J (Clin Res Ed) (1984) 1.01
Pseudomonas pseudomallei in an anopthalmic orbit. Arch Ophthalmol (1980) 1.01
Evaluation of pilus vaccines for prevention of experimental otitis media caused by nontypable Haemophilus influenzae. Pediatr Infect Dis J (1989) 1.01
Prevalence of human astrovirus serotype 4: capsid protein sequence and comparison with other strains. Epidemiol Infect (1995) 1.01
Assessment of interpersonal problem-solving skills. Psychiatry (1990) 1.00
Luminescence control in the marine bacterium Vibrio fischeri: An analysis of the dynamics of lux regulation. J Mol Biol (2000) 1.00
The function of health facilities in the total medical care complex. Public Health Rep (1966) 0.96
The carbonic anhydrases of some guinea-pig tissues. Biochim Biophys Acta (1970) 0.96
Using an efficient biofilm detaching agent: an essential step for the improvement of endoscope reprocessing protocols. J Hosp Infect (2006) 0.96